Company Filing History:
Years Active: 1996-2004
Title: Innovations by David A. Lowe: Pioneering Advances in Enzymatic Processes
Introduction
David A. Lowe, an inventive mind hailing from Fayetteville, NY, has made significant contributions to the field of enzymatic biotechnology. With a remarkable portfolio of 2 patents, his work represents a fusion of creativity and scientific rigor aimed at enhancing industrial applications.
Latest Patents
Lowe's latest patents showcase his expertise in enzymatic processes. The first is titled "D-hydantoinase from Ochrobactrum anthropi," which pertains to a novel D-hydantoinase enzyme capable of enantio-selectively hydrolyzing D-hydantoins into their corresponding D-N-carbamoyl-amino acids. This invention also includes the nucleic acids encoding the enzyme, expression vectors, and host cells equipped to express it. The second patent, "Enzymatic acylation of 3-hydroxymethyl cephalosporins," involves the production of O-acylated cephalosporins through the reaction of 3-hydroxymethyl cephalosporins with specific acyl donors. This process utilizes various enzymes, including the esterase from Rodosporidium toruloides, facilitating the reaction in whole cells or in either soluble or immobilized forms.
Career Highlights
David A. Lowe is currently associated with Bristol-Myers Squibb Company, a leading global biopharmaceutical company known for its innovative drugs and therapeutic solutions. His role there allows him to engage in cutting-edge research, further emphasizing the impact of his patented work on the wider industry.
Collaborations
Throughout his career, Lowe has collaborated with notable colleagues including Michael Politino and Guna Romancik. This collaboration has likely enriched his research, blending diverse skills and expertise within the industry.
Conclusion
With a passion for enzymatic innovations, David A. Lowe exemplifies the spirit of inventiveness in biotechnology. His patents not only contribute to academic research but also hold potential for practical applications in various industries, promising advancements in biochemistry and pharmaceuticals.